Piloting home infusions of Tysabri (natalizumab): a randomised crossover trial
We developed a new model of care for home infusions of natalizumab for people with multiple sclerosis. The new model of care was then tested in a pilot study comparing home infusions of natalizumab with usual care (attendance in an ambulatory care day units) using an AB/BA randomised crossover trial...
Main Authors: | Tim Schultz, Anne Thomas, Paul Georgiou, Mahasen Juaton, Lorraine Simon, Lynette Cusack, Kerisha Naidoo, Kevin Webb, Jon Karnon |
---|---|
Format: | Article |
Language: | English |
Published: |
Ubiquity Press
2019-08-01
|
Series: | International Journal of Integrated Care |
Subjects: | |
Online Access: | https://www.ijic.org/articles/5372 |
Similar Items
-
Home infusions of natalizumab for people with multiple sclerosis: a pilot randomised crossover trial
by: Timothy J. Schultz, et al.
Published: (2021-08-01) -
Patient monitoring during treatment with natalizumab (ORP-24)
by: Zohreh Abna
Published: (2023-01-01) -
Natalizumab Pharmacokinetics and -Dynamics and Serum Neurofilament in Patients With Multiple Sclerosis
by: Undine Proschmann, et al.
Published: (2021-04-01) -
Natalizumab-Induced Pustular Psoriasis of Palms and Soles
by: Bengisu Ozarslan, et al.
Published: (2022-05-01) -
Pulmonary eosinophilia associated to treatment with natalizumab
by: Elena Curto, et al.
Published: (2016-01-01)